Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease.
about
The non-protein amino acid BMAA is misincorporated into human proteins in place of L-serine causing protein misfolding and aggregationDietary BMAA exposure in an amyotrophic lateral sclerosis cluster from southern FranceMaternal transfer of the cyanobacterial neurotoxin β-N-methylamino-L-alanine (BMAA) via milk to suckling offspringThe emerging science of BMAA: do cyanobacteria contribute to neurodegenerative disease?Lead exposure and tremor among older men: the VA Normative Aging StudyCyanobacterial blooms and the occurrence of the neurotoxin, beta-N-methylamino-l-alanine (BMAA), in South Florida aquatic food websAmyotrophic lateral sclerosis and environmental factorsRisk factors for amyotrophic lateral sclerosisThinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signalingThe cyanobacteria derived toxin Beta-N-methylamino-L-alanine and amyotrophic lateral sclerosisSmall GSK-3 Inhibitor Shows Efficacy in a Motor Neuron Disease Murine Model Modulating AutophagyIntracellular fibril formation, calcification, and enrichment of chaperones, cytoskeletal, and intermediate filament proteins in the adult hippocampus CA1 following neonatal exposure to the nonprotein amino acid BMAACyanobacterial neurotoxin β-N-methylamino-L-alanine (BMAA) in shark finsAnalytical techniques for the detection of α-amino-β-methylaminopropionic acidDietary exposure to an environmental toxin triggers neurofibrillary tangles and amyloid deposits in the brainSearching for a link between the L-BMAA neurotoxin and amyotrophic lateral sclerosis: a study protocol of the French BMAALS programmeMapping amyotrophic lateral sclerosis lake risk factors across northern New EnglandEquilibrium Dynamics of β-N-Methylamino-L-Alanine (BMAA) and Its Carbamate Adducts at Physiological ConditionsCyanobacterial Neurotoxin BMAA and Mercury in SharksNeonatal exposure to the cyanobacterial toxin BMAA induces changes in protein expression and neurodegeneration in adult hippocampusParkinson-dementia complex and development of a new stable isotope dilution assay for BMAA detection in tissueCurrent pathways for epidemiological research in amyotrophic lateral sclerosis.Cyanobacterial Toxins of the Laurentian Great Lakes, Their Toxicological Effects, and Numerical Limits in Drinking WaterHigh resolution metabolite imaging in the hippocampus following neonatal exposure to the environmental toxin BMAA using ToF-SIMSTransfer of a cyanobacterial neurotoxin within a temperate aquatic ecosystem suggests pathways for human exposureBMAA--an unusual cyanobacterial neurotoxin.Natural toxins implicated in the development of Parkinson's disease.A comparative study on three analytical methods for the determination of the neurotoxin BMAA in cyanobacteriaMistranslation of the genetic code.Cyanobacteria and BMAA exposure from desert dust: a possible link to sporadic ALS among Gulf War veterans.β-N-methylamino-L-alanine induces neurological deficits and shortened life span in DrosophilaBiotransfer of β-N-methylamino-L-alanine (BMAA) in a eutrophicated freshwater lake.Geographic Variation of Amyotrophic Lateral Sclerosis Incidence in New Jersey, 2009-2011.MALDI imaging delineates hippocampal glycosphingolipid changes associated with neurotoxin induced proteopathy following neonatal BMAA exposure.Acute β-N-Methylamino-L-alanine Toxicity in a Mouse Model.A Temporal Association between Accumulated Petrol (Gasoline) Lead Emissions and Motor Neuron Disease in Australia.Functional classification of skeletal muscle networks. II. Applications to pathophysiology.Exposure to environmental toxicants and pathogenesis of amyotrophic lateral sclerosis: state of the art and research perspectives.C9ORF72 intermediate repeat copies are a significant risk factor for Parkinson disease.β-methylamino-L-alanine (BMAA) is not found in the brains of patients with confirmed Alzheimer's disease
P2860
Q21004125-3E8E028A-F080-4CE7-8DDE-00A127187496Q21132388-C33290E5-0AAF-49E5-9A1F-1EB80D4A812DQ21559548-38A8BCB9-27E1-4363-BFD1-D801EE7CB461Q22306133-E6B1B265-4176-4190-9913-A6FE9549E64CQ23915303-4FEB6917-5FE9-47BA-A442-2559290569A1Q24618334-C98759F6-2B36-4993-BA65-47E1F0FE0E6BQ26749342-6717123B-CC68-4EAC-918F-E0A3209E6C7DQ26827642-E95BE2C2-CEA7-4A1E-A082-9978152B6A93Q26864995-8D7BBE39-880F-4931-A292-636351E20DC6Q26999594-DFC3AFA0-A3C5-4DAB-94DF-48155C452423Q27322519-D3E9BE3A-0E86-42EB-A874-DCA124B2A26FQ28239546-CAEFCC8E-8A80-4FE2-B69D-C22D49F32B6FQ28261789-AFBBF5F3-4033-4B3B-8E19-8F6FDDC5CCE8Q28261995-4C608951-91AE-4C5A-8A0A-A7E3AD993143Q28272327-6B01FD2B-4BED-43DF-8FF1-A5C5FC26DCB8Q28393837-04236BC8-6945-490A-A46A-38BE54485017Q28395864-DCE843BF-A62C-4658-935E-A2274873E43DQ28553466-7889966F-BFAF-455A-B5D3-CFE4C910FE03Q28597174-5CA6A450-3BCD-4545-B8B7-17F77CFE38D9Q30460930-A3DA0603-A531-43BC-9F17-66D512A76110Q33498266-A43B896C-194B-47B9-8077-ED1D6C916C7CQ33697436-0A6EC364-2564-4831-B6D2-C42114363222Q33833344-1C825642-D2F3-4DA3-84D4-BF66715764F5Q33918172-4E17F341-E7B3-492B-A853-EC2C2F595AE0Q33927137-5ADE562E-B371-4CE3-B961-2412F415904CQ34020249-4A2E48F7-7115-4D32-9088-4358A887AA20Q34029794-A3661AAF-F749-4C8F-BDAC-E43F2A6A2DFBQ34263391-9B67EAFB-5CE3-47BE-B8E6-9B1EFDF14E1FQ34438631-7B8A5E6B-B53D-4107-8B30-78816B9C7548Q35013969-A7CCA02E-3090-47D7-9CD5-27F121068C64Q35155641-167CBC60-561D-424C-A749-95B06361FDCAQ35228202-21FE0343-1A7A-4C07-8199-E5EA0B740072Q36045089-F58E50B6-4D9B-41B5-8802-8FAA8BAA4B07Q36221110-62867ED8-BC1E-4ACE-A1C3-E247E1DA9912Q36271885-E096D310-125F-4ADE-A24F-62AEC0D75AB8Q36403811-C1C8A549-C607-438D-896B-EDE1FFA901EEQ36530917-9C0C62B5-AC47-4389-99C2-4DBADFB16ED6Q37139024-DB581064-B801-4DEA-999C-812FECA9D928Q37273743-84681782-2AFF-4795-BDAB-EF779E838A21Q37399596-67A06B9E-4660-4183-A3C7-2B72F6DB3777
P2860
Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease.
@en
Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease.
@nl
type
label
Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease.
@en
Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease.
@nl
prefLabel
Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease.
@en
Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease.
@nl
P2093
P2860
P921
P1476
Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease.
@en
P2093
S A Banack
S Papapetropoulos
T E Johnson
W G Bradley
P2860
P304
P356
10.1111/J.1600-0404.2008.01150.X
P407
P50
P577
2009-02-26T00:00:00Z